Cardlytics, Inc.
CDLX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $87 | $94 | $189 |
| - Cash | $44 | $47 | $52 | $66 |
| + Debt | $174 | $220 | $221 | $222 |
| Enterprise Value | – | $261 | $263 | $345 |
| Revenue | $52 | $63 | $62 | $74 |
| % Growth | -17.7% | 2.2% | -16.4% | – |
| Gross Profit | $24 | $29 | $25 | $33 |
| % Margin | 46.7% | 46.3% | 40.6% | 44.2% |
| EBITDA | -$63 | $0 | -$4 | -$7 |
| % Margin | -121.6% | 0% | -6.4% | -9.1% |
| Net Income | -$73 | -$9 | -$13 | -$16 |
| % Margin | -139.7% | -14.7% | -21.5% | -21.1% |
| EPS Diluted | -1.36 | -0.18 | -0.26 | -0.31 |
| % Growth | -655.6% | 30.8% | 16.1% | – |
| Operating Cash Flow | $2 | $1 | -$7 | $3 |
| Capital Expenditures | -$4 | $0 | $0 | -$4 |
| Free Cash Flow | -$3 | $1 | -$7 | -$1 |